Strengthen evidence capability without creating unnecessary burden
AIM4ALL provides a structured path from fragmented data environments and one-off reimbursement negotiations to a repeatable model of innovation partnership, longitudinal evidence generation and service delivery.
The approach is designed to integrate with Health System priorities while minimising additional operational burden.
Benefits
Attract clinical research: strengthen the Health System's position as a destination for innovative clinical trials.
Generate relevant evidence earlier: capture payer- and HTA-relevant information throughout the product lifecycle.
Reduce decision uncertainty: improve the quality and continuity of evidence used in access and reimbursement decisions.
Enable innovative contracts: create the data foundation required for value- and outcomes-based agreements.
Improve affordability planning: increase visibility of eligible populations, outcomes, value and potential financial exposure.
Preserve data sovereignty: participate in cross-jurisdictional learning while retaining control of national data.